


Oragen Therapeutics Revenue
Biotechnology Research • • 1-10 Employees
Oragen Therapeutics revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Key Contact at Oragen Therapeutics
Thomas Stalder
Chief Technology Officer
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Founded | 2025 |
| Employees | 1-10 |
About Oragen Therapeutics
We are a preclinical-stage biotech company focused on developing revolutionary therapies to address Inflammatory Bowel Diseases. Harnessing the unique capabilities of our Genetic Medicines Oral Delivery platform we aim to overcome major limitations of current treatments and unlock the groundbreaking potential of Genetic Medicines in IBDs, driving transformative change in a field with critical medical needs.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Oragen Therapeutics has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Oragen Therapeutics has never raised funding before.
Frequently asked questions
4.8
40,000 users



